Unknown

Dataset Information

0

Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes.


ABSTRACT: Vincristine is an effective chemotherapeutic drug for various cancers, including acute lymphoblastic leukemia (ALL). Unfortunately, clinical utility is restricted by dose-limiting vincristine-induced peripheral neuropathies (VIPN). We sought to determine the association of VIPN with a recently identified risk variant, CEP72 rs924607, and drug absorption, distribution, metabolism, and excretion (ADME) gene variants in pediatric ALL. This was followed by a meta-analysis of pharmacogenomic data from over 500 patients. CEP72 rs924607 was significantly associated with VIPN (P = 0.02; odds ratio (OR) = 3.4). ADME analyses identified associations between VIPN and ABCC1 rs3784867 (P = 5.34 × 10-5 ; OR = 4.9), and SLC5A7 rs1013940 (P = 9.00 × 10-4 ; OR= 8.6); genes involved in vincristine transport and inherited neuropathies, respectively. Meta-analysis identified an association with a variant related to TTPA (rs10504361: P = 6.85 × 10-4 ; OR = 2.0), a heritable neuropathy-related gene. This study provides essential corroboratory evidence for CEP72 rs924607 and highlights the importance of drug transporter and inherited neuropathy genes in VIPN.

SUBMITTER: Wright GEB 

PROVIDER: S-EPMC6519044 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes.

Wright Galen E B GEB   Amstutz Ursula U   Drögemöller Britt I BI   Shih Joanne J   Rassekh Shahrad R SR   Hayden Michael R MR   Carleton Bruce C BC   Ross Colin J D CJD  

Clinical pharmacology and therapeutics 20180817 2


Vincristine is an effective chemotherapeutic drug for various cancers, including acute lymphoblastic leukemia (ALL). Unfortunately, clinical utility is restricted by dose-limiting vincristine-induced peripheral neuropathies (VIPN). We sought to determine the association of VIPN with a recently identified risk variant, CEP72 rs924607, and drug absorption, distribution, metabolism, and excretion (ADME) gene variants in pediatric ALL. This was followed by a meta-analysis of pharmacogenomic data fro  ...[more]

Similar Datasets

| S-EPMC6355340 | biostudies-literature
| S-EPMC5126263 | biostudies-literature
| S-EPMC8316236 | biostudies-literature
| S-EPMC5320866 | biostudies-literature
| S-EPMC9321338 | biostudies-literature
| S-EPMC7295796 | biostudies-literature
| S-EPMC4377066 | biostudies-literature
| S-EPMC5840884 | biostudies-literature
| S-EPMC9525541 | biostudies-literature
| S-EPMC9302309 | biostudies-literature